PRKG1, protein kinase cGMP-dependent 1, 5592

N. diseases: 114; N. variants: 20
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C1849508
Disease: EPILEPSY, PYRIDOXINE-DEPENDENT
EPILEPSY, PYRIDOXINE-DEPENDENT
0.020 Biomarker disease BEFREE Within this review, the NO/sGC/cGMP/PKG/PDE-signaling cascade and the major pharmacological intervention sites are described. 29604206 2018
CUI: C0007222
Disease: Cardiovascular Diseases
Cardiovascular Diseases
0.010 AlteredExpression group BEFREE We found that PKG-1α enzyme activity was attenuated by exposure to the NO donor, spermine NONOate, hydrogen peroxide, and peroxynitrite but not by superoxide, suggesting that the attenuation of PKG-1α activity may be an under-appreciated mechanism underlying the development of endothelial dysfunction in a number of cardiovascular diseases. 21600289 2011
CUI: C0856169
Disease: Endothelial dysfunction
Endothelial dysfunction
0.010 AlteredExpression phenotype BEFREE We found that PKG-1α enzyme activity was attenuated by exposure to the NO donor, spermine NONOate, hydrogen peroxide, and peroxynitrite but not by superoxide, suggesting that the attenuation of PKG-1α activity may be an under-appreciated mechanism underlying the development of endothelial dysfunction in a number of cardiovascular diseases. 21600289 2011
Diabetes Mellitus, Non-Insulin-Dependent
0.030 Biomarker disease BEFREE We conducted a retrospective analysis of data on 37 CGK-MODY patients consisting of 21 girls and 16 boys of ages 1.9-20.1 (mean 12.5±5.2) years, treated in our centre in the time period between 2002 and 2013. 28663157 2017
Maturity onset diabetes mellitus in young
0.010 Biomarker disease BEFREE We conducted a retrospective analysis of data on 37 CGK-MODY patients consisting of 21 girls and 16 boys of ages 1.9-20.1 (mean 12.5±5.2) years, treated in our centre in the time period between 2002 and 2013. 28663157 2017
CUI: C0027055
Disease: Myocardial Reperfusion Injury
Myocardial Reperfusion Injury
0.200 Therapeutic phenotype RGD Vardenafil protects isolated rat hearts at reperfusion dependent on GC and PKG. 18332860 2008
CUI: C0015672
Disease: Fatigue
Fatigue
0.010 Biomarker phenotype BEFREE Using selective inhibitors of either PKG or cysteine proteases to separately inhibit the sequential steps in membrane perforation, combined with video microscopy, electron tomography, electron energy loss spectroscopy, and soft X-ray tomography of mature intracellular <i>Plasmodium falciparum</i> parasites, we resolve intermediate steps in egress. 28292906 2017
CUI: C0027796
Disease: Neuralgia
Neuralgia
0.310 Biomarker phenotype CTD_human Two isoforms of cyclic GMP-dependent kinase-I exhibit distinct expression patterns in the adult mouse dorsal root ganglion. 30152261 2018
CUI: C0038870
Disease: Neuralgia, Supraorbital
Neuralgia, Supraorbital
0.300 Biomarker phenotype CTD_human Two isoforms of cyclic GMP-dependent kinase-I exhibit distinct expression patterns in the adult mouse dorsal root ganglion. 30152261 2018
CUI: C0042656
Disease: Neuralgia, Vidian
Neuralgia, Vidian
0.300 Biomarker phenotype CTD_human Two isoforms of cyclic GMP-dependent kinase-I exhibit distinct expression patterns in the adult mouse dorsal root ganglion. 30152261 2018
CUI: C0234247
Disease: Neuralgia, Atypical
Neuralgia, Atypical
0.300 Biomarker phenotype CTD_human Two isoforms of cyclic GMP-dependent kinase-I exhibit distinct expression patterns in the adult mouse dorsal root ganglion. 30152261 2018
CUI: C0234249
Disease: Neuralgia, Stump
Neuralgia, Stump
0.300 Biomarker phenotype CTD_human Two isoforms of cyclic GMP-dependent kinase-I exhibit distinct expression patterns in the adult mouse dorsal root ganglion. 30152261 2018
CUI: C0423711
Disease: Neuralgia, Perineal
Neuralgia, Perineal
0.300 Biomarker phenotype CTD_human Two isoforms of cyclic GMP-dependent kinase-I exhibit distinct expression patterns in the adult mouse dorsal root ganglion. 30152261 2018
CUI: C0423712
Disease: Neuralgia, Iliohypogastric Nerve
Neuralgia, Iliohypogastric Nerve
0.300 Biomarker phenotype CTD_human Two isoforms of cyclic GMP-dependent kinase-I exhibit distinct expression patterns in the adult mouse dorsal root ganglion. 30152261 2018
CUI: C0751371
Disease: Neuralgia, Ilioinguinal
Neuralgia, Ilioinguinal
0.300 Biomarker phenotype CTD_human Two isoforms of cyclic GMP-dependent kinase-I exhibit distinct expression patterns in the adult mouse dorsal root ganglion. 30152261 2018
CUI: C0751372
Disease: Nerve Pain
Nerve Pain
0.300 Biomarker phenotype CTD_human Two isoforms of cyclic GMP-dependent kinase-I exhibit distinct expression patterns in the adult mouse dorsal root ganglion. 30152261 2018
CUI: C0751373
Disease: Paroxysmal Nerve Pain
Paroxysmal Nerve Pain
0.300 Biomarker phenotype CTD_human Two isoforms of cyclic GMP-dependent kinase-I exhibit distinct expression patterns in the adult mouse dorsal root ganglion. 30152261 2018
CUI: C4049446
Disease: Neointimal hyperplasia
Neointimal hyperplasia
0.010 Biomarker disease BEFREE Translocator protein 18 kDa ligand alleviates neointimal hyperplasia in the diabetic rat artery injury model via activating PKG. 30738868 2019
CUI: C0030193
Disease: Pain
Pain
0.210 AlteredExpression phenotype BEFREE To evaluate its antinociceptive potential, we used 2 animal models in which the pain involves both activated PKG-1α and LTH. 28059868 2017
CUI: C0020538
Disease: Hypertensive disease
Hypertensive disease
0.340 Biomarker group BEFREE Thus, the NF-κB/miR-155-5p/PKG1 axis may be crucial in the pathogenesis of inflammatory vascular diseases, such as atherosclerotic intimal hyperplasia and preeclamptic hypertension. 30104414 2018
CUI: C0006826
Disease: Malignant Neoplasms
Malignant Neoplasms
0.010 Biomarker group BEFREE These findings suggest that PDE10 can be targeted for cancer therapy or prevention whereby inhibition results in cGMP elevation and PKG activation to reduce β-catenin-mediated transcription of survival proteins leading to the selective apoptosis of cancer cells. 26713600 2016
CUI: C1306459
Disease: Primary malignant neoplasm
Primary malignant neoplasm
0.010 Biomarker group BEFREE These findings suggest that PDE10 can be targeted for cancer therapy or prevention whereby inhibition results in cGMP elevation and PKG activation to reduce β-catenin-mediated transcription of survival proteins leading to the selective apoptosis of cancer cells. 26713600 2016
CUI: C0028754
Disease: Obesity
Obesity
0.220 AlteredExpression disease BEFREE The transcriptional regulation of adipogenesis in obesity is influenced by AGC (protein kinase A (PKA), PKG, PKC) family signaling kinases. 28585197 2017
CUI: C0036920
Disease: Sezary Syndrome
Sezary Syndrome
0.300 Biomarker disease CTD_human The mutational landscape of cutaneous T cell lymphoma and Sézary syndrome. 26551667 2015
CUI: C0005779
Disease: Blood Coagulation Disorders
Blood Coagulation Disorders
0.010 Biomarker group BEFREE The diagnostic performance of PTr-CGK to predict coagulopathy was established by analysis of receiver operating characteristic curves. 29707780 2018